Since 1999

Our History

More than 27 years of precision manufacturing, clinical innovation, and a singular mission: helping prevent diabetic amputations, one monofilament at a time.

How it started

A problem worth solving

In 1999, a clinician frustrated by inconsistent, poorly manufactured monofilaments decided there had to be a better way. The standard tools available to detect diabetic peripheral neuropathy were unreliable, variable in force, inconsistent in manufacturing, and expensive to source reliably.

Medical Monofilament was founded in Plymouth, Massachusetts with a single goal: engineer a monofilament that clinicians could trust completely. Every unit, every time, a 10 gram force range, ±1.5 g.

That founding obsession with precision has never changed.

1999
Year founded in Plymouth, MA
Women-owned and independently operated from day one. No outside investors. No compromises on quality.
Milestones

27+ years of progress

1999

Founded in Plymouth, MA

Medical Monofilament Manufacturing is established with a mission to produce the most consistent, clinically reliable monofilament available. Production begins out of a small facility on Camelot Drive, women-owned, independently operated, and built on an obsession with precision.

Early 2000s

Patented automated manufacturing

We developed and patented a proprietary automated manufacturing process that eliminated human variability in production. Precision inline sensors and visual inspection systems were integrated into every production run.

2005

FDA 510(k) Clearance

Medical Monofilament became the only monofilament manufacturer in the United States to receive FDA 510(k) clearance, validating our manufacturing process and giving clinicians the regulatory assurance they needed.

2010s

National distribution growth

Partnerships with national distributors brought the 5.07 monofilament into podiatry offices, wound care centers, and diabetes clinics across North America. Clinical adoption grew steadily as word spread about our consistency and reliability.

2020s

Direct-to-practice and expanded access

We launched direct ordering for practices of all sizes, introduced bulk and Open PO programs for hospital systems, and expanded international availability to bring the gold standard monofilament to clinicians worldwide.

Today

Still independent. Still in Plymouth.

Same address. Same mission. Every monofilament still overseen at 121 Camelot Drive. Women-owned, FDA cleared, and committed to the 10 gram force range, ±1.5 g, that has protected patients for more than 27 years.

27+
Years in operation
10g
±1.5 g force range, every unit
1
U.S. FDA 510(k) cleared manufacturer
100%
American made

Ready to experience the difference?

Join thousands of clinicians who trust Medical Monofilament for accurate, consistent diabetic foot screening.